Put a ring on it: application of small aliphatic rings in medicinal chemistry

MR Bauer, P Di Fruscia, SCC Lucas… - RSC Medicinal …, 2021 - pubs.rsc.org
Aliphatic three-and four-membered rings including cyclopropanes, cyclobutanes, oxetanes,
azetidines and bicyclo [1.1. 1] pentanes have been increasingly exploited in medicinal …

Fsp3: A new parameter for drug-likeness

W Wei, S Cherukupalli, L Jing, X Liu, P Zhan - Drug Discovery Today, 2020 - Elsevier
Highlights•Drug-likeness refers to the similarity between compounds and drugs; drug-like
compounds are more likely to be transformed into drugs.•Chemical structures with enhanced …

Cyclobutanes in small‐molecule drug candidates

MR van der Kolk, MACH Janssen, FPJT Rutjes… - …, 2022 - Wiley Online Library
Cyclobutanes are increasingly used in medicinal chemistry in the search for relevant
biological properties. Important characteristics of the cyclobutane ring include its unique …

Small-molecule inhibitors of tankyrases as prospective therapeutics for cancer

M Yu, Y Yang, M Sykes, S Wang - Journal of Medicinal Chemistry, 2022 - ACS Publications
Tankyrases are multifunctional poly (adenosine diphosphate-ribose) polymerases that
regulate diverse biological processes including telomere maintenance and cellular …

Small-molecule inhibitors targeting the canonical WNT signaling pathway for the treatment of cancer

Z Liu, P Wang, EA Wold, Q Song, C Zhao… - Journal of medicinal …, 2021 - ACS Publications
Canonical WNT signaling is an important developmental pathway that has attracted
increased attention for anticancer drug discovery. From the production and secretion of WNT …

Molecular dynamics study of conformational changes of Tankyrase 2 binding subsites upon ligand binding

Y Hirano, N Okimoto, S Fujita, M Taiji - ACS omega, 2021 - ACS Publications
The interactions between proteins and ligands are involved in various biological functions.
While experimental structures provide key static structural information of ligand-unbound …

Recent development of 1, 2, 4-triazole-containing compounds as anticancer agents

X Wen, Y Zhou, J Zeng, X Liu - Current Topics in Medicinal …, 2020 - ingentaconnect.com
1, 2, 4-Triazole derivatives possess promising in vitro and in vivo anticancer activity, and
many anticancer agents such as fluconazole, tebuconazole, triadimefon, and ribavirin bear a …

Development of a 1, 2, 4-triazole-based lead tankyrase inhibitor: part II

RGG Leenders, SA Brinch, ST Sowa… - Journal of Medicinal …, 2021 - ACS Publications
Tankyrase 1 and 2 (TNKS1/2) catalyze post-translational modification by poly-ADP-
ribosylation of a plethora of target proteins. In this function, TNKS1/2 also impact the WNT/β …

Discovery of novel spiroindoline derivatives as selective tankyrase inhibitors

F Shirai, T Tsumura, Y Yashiroda, H Yuki… - Journal of Medicinal …, 2019 - ACS Publications
The canonical WNT pathway plays an important role in cancer pathogenesis. Inhibition of
poly (ADP-ribose) polymerase catalytic activity of the tankyrases (TNKS/TNKS2) has been …

Insights of tankyrases: a novel target for drug discovery

MG Damale, SK Pathan, DB Shinde, RH Patil… - European journal of …, 2020 - Elsevier
Tankyrases are the group of enzymes belonging to a class of Poly (ADP-ribose) polymerase
(PARP) recently named ADP-ribosyltransferase (ARTD). The two isoforms of tankyrase ie …